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Abstract We reported that an inhibitor of sphingolipid
biosynthesis, D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-
1-propanol (PDMP), blocks brefeldin A (BFA)-induced retro-
grade membrane transport from the Golgi complex to the
endoplasmic reticulum (ER) (Kok et al., 1998, J. Cell Biol. 142,
25^38). We now show that PDMP partially blocks the BFA-
induced ADP-ribosylation of the cytosolic protein BARS-50.
Moreover, PDMP does not interfere with the BFA-induced
inhibition of the binding of ADP-ribosylation factor (ARF) and
the coatomer component L-coat protein to Golgi membranes.
These results are consistent with a role of ADP-ribosylation in
the action of BFA and with the involvement of BARS-50 in the
regulation of membrane trafficking.
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1. Introduction
The Golgi complex (GC) regulates post-translational and
sorting events of the biosecretory pathway. However, the
mechanism(s) of transport from the endoplasmic reticulum
(ER) to the GC, between the Golgi cisternae and from Golgi
to plasma membrane or intracellular destinations are contro-
versial [2^4]. Despite the continual discovery of molecules in-
volved in membrane transport, the molecular mechanisms re-
main rather obscure. The use of the fungal macrocyclic
lactone brefeldin A (BFA) revealed a retrograde membrane
£ow pathway from the GC to the ER [5^8], which under
normal conditions is in balance with the anterograde mem-
brane £ow that ensures the transfer of lipids and proteins
from the ER to the GC. BFA causes a rapid and explosive
disruption of the GC, involving the formation of long tubules
that redistribute most of the Golgi-resident membrane com-
ponents into the ER [9]. The Golgi disorganization produced
by BFA is initiated by the release of coat proteins (COPs)
from Golgi membranes [9,10] and the small GTP binding
protein ADP-ribosylation factor (ARF) [11,12]. This sensitiv-
ity to BFA is a test of the association of these components
with Golgi membranes in vivo. Although the molecular mech-
anisms of the BFA e¡ects are in part due to the inhibition of
GDP-GTP exchange of ARF [11,12], it is also known that this
drug induces speci¢c mono-ADP-ribosylation of two cytosol-
ic proteins of 38 and 50 kDa [13]. The former is the glyco-
lytic enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and the later, named BARS-50, binds GTP and
is regulated by heterotrimeric G proteins [14]. Recently, it
has been shown that (i) inhibitors of the BFA-dependent
ADP-ribosylation prevent the Golgi disassembly induced by
BFA [15], (ii) NAD (a substrate of the ADP-ribosylation
reaction) is required for the BFA-induced disassembly of the
GC, (iii) pre-ADP-ribosylated cytosol mimics the e¡ect of
NAD and (iv) the further addition of native BARS-50 abol-
ishes the ability of pre-ADP-ribosylated cytosol to sustain the
e¡ect of BFA (in the absence of NAD) [16]. Thus, there is
correlative evidence for a role of ADP-ribosylation in BFA-
induced Golgi disassembly, while BARS-50 appears to be an
essential component involved in the membrane £ow in this
organelle [16^18].
It is possible to antagonize the e¡ect of BFA without pre-
venting the L-COP detachment from the GC [1,19]. This ob-
servation suggests that this early event is necessary but not
su⁄cient to induce the complete disassembly of the GC by
BFA. Of particular interest is the inhibitor of sphingolipid
biosynthesis D,L-threo-1-phenyl-2-decanoylamino-3-morpholi-
no-1-propanol (PDMP) [20]. Apart from its e¡ect on gluco-
sylceramide biosynthesis, PDMP inhibits anterograde mem-
brane transport through the GC and from the GC to
plasma membrane, probably by increasing the intracellular
ceramide levels [21,22]. More recently, PDMP has been shown
to block the BFA-induced retrograde membrane £ow from
Golgi to ER through local changes in calcium homeostasis [1].
We now provide evidence that the inhibitory e¡ect of
PDMP on the BFA-induced retrograde membrane £ow in-
volves inhibition of BFA-dependent ADP-ribosylation of the
cytosolic protein BARS-50.
2. Material and methods
2.1. Antibodies and other reagents
The anti-ARF monoclonal antibody (mAb 1D9) was a gift from
R.A. Kahn (National Cancer Institute, NIH, Bethesda, MD, USA),
the anti-L-COP monoclonal antibody, NAD and BFA were obtained
from Sigma (St. Louis, MO, USA). PDMP and lyso-PDMP were
purchased from Matreya (Pleasant Gap, PA, USA).
2.2. ARF and L-COP binding assay
Measurement of ARF and L-COP binding to Golgi membranes was
performed as described [23].
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2.3. ADP-ribosylation assay
The ADP-ribosylation assay using Golgi membranes and rat brain
cytosol was performed as previously described [16]. The maximal
ADP-ribosylation of BARS-50 (s 90%) was obtained using 200 WM
NAD and 100 WM BFA for 60 min at 37‡C. The radioactivity bound
to BARS-50 and GAPDH was measured by electronic autoradiogra-
phy using an Instant Imager (Packard).
3. Results and discussion
3.1. PDMP inhibits the BFA-induced ADP-ribosylation of
BARS-50
Fig. 1 shows the dose-response e¡ect of PDMP on the
BFA-induced ADP-ribosylation of the cytosolic protein
BARS-50. The speci¢c ADP-ribosylation induced by BFA
was partially inhibited by PDMP. The inhibitory e¡ect of
PDMP was speci¢c for PDMP, as lyso-PDMP did not block
the BFA-induced ADP-ribosylation of BARS-50. This was
consistent with the absence of an e¡ect of lyso-PDMP on
BFA-induced GC to ER membrane £ow in intact cells [1].
The PDMP inhibition of BFA-induced ADP-ribosylation
was lower than that of other inhibitors such as dicumarol
[15]. However, both agents produce similar morphological
e¡ects by inhibiting the fusion of the GC with the ER in
NRK cells [1,16]. Importantly, the blocking e¡ect of the
BFA-induced relocalization of Golgi lipids and proteins to
the ER is absolute when PDMP was administered 15 min
before BFA. However, when cells are co-incubated with
PDMP and BFA, the GC stained with NBD-C6-Cer presents
long tubules [1]. Here, we have observed that PDMP inhibited
BFA-induced ADP-ribosylation of BARS-50 more strongly
when it was added 15 min before BFA than when membranes
were co-incubated with PDMP and BFA (Fig. 2). Again, lyso-
PDMP had no signi¢cant e¡ects.
3.2. PDMP does not alter the e¡ect of BFA on ARF and
L-COP binding to isolated Golgi membranes
One of the earliest e¡ects of BFA is the redistribution of
ARF and the coatomer component L-COP from the GC into
the cytosol [10]. This is followed by the formation of tubules,
emerging from the GC, that instantly fuse with the ER. Con-
sequently, the resident Golgi membrane components redistrib-
ute into the ER [5,6]. Importantly, PDMP does not impair the
L-COP redistribution induced by BFA but completely pre-
served the GC morphology and prevented the redistribution
of Golgi enzymes (such as mannosidase II) or lipids (NBD-
C6-Cer) into the ER [1]. Since the ARF and coatomer binding
to Golgi membranes is a crucial step in the formation of
transport carriers [8], we here studied whether the ARF and
L-COP binding to GC in the presence of BFA was altered by
PDMP. PDMP did not alter the e¡ect of BFA on ARF (Fig.
3) or L-COP (data not shown) binding to isolated Golgi mem-
branes. This result indicates that the target of PDMP is an
Fig. 1. PDMP but not lyso-PDMP inhibited the BFA-induced
ADP-ribosylation of BARS-50 in a dose-dependent manner.
Fig. 2. The PDMP-induced inhibition of the ADP-ribosylation of
BARS-50 was more marked when Golgi membranes are ¢rst pre-in-
cubated with PDMP than when co-incubated with BFA+PDMP.
Fig. 3. PDMP did not a¡ect the e¡ect of BFA on ARF binding to
Golgi membranes in vitro.
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event that occurs after the binding of these two molecular
components to Golgi membranes.
Previous experiments suggest that BFA-induced ADP-ribo-
sylation is important in the regulation of the structure and
function of the GC [16,17]. BARS-50 is the main target of
BFA-induced ADP-ribosylation and it might downregulate
the tubulation process [18], for example, regulating the mem-
brane ¢ssion process of Golgi-derived tubular intermediates.
Although the inhibitory e¡ect of PDMP on the BFA-induced
ADP-ribosylation of BARS-50 is not complete, it is reason-
able to conclude that this post-translational modi¢cation
plays a role in the inhibitory e¡ect of PDMP on BFA-induced
retrograde membrane £ow. This e¡ect of PDMP appears to
be independent of its e¡ect on calcium homeostasis [1], since
the ADP-ribosylation reaction is not regulated by calcium.
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